[
    {
        "identifier": "spanish3512",
        "title": "Consejos de Seguridad para Mantener Seguros a los Trabajadores en los Sitios de Vacunación Contra el Virus COVID-19",
        "text": "\nde vacunas deben estar adecuadamente capacitadas en la norma sobre patógenos de transmisión sanguínea de OSHA (29 CFR 1910.1030) y recibir capacitación adicional según sea necesario. osha.gov/coronavirus Este documento no tiene el vigor ni el efecto de la ley y de ninguna manera pretende operar como una obligación para el público.Este documento solamente tiene el fin de brindar claridad al público\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
            "id": "ConsejosdeSeguridadparaMantenerSegurosalosTrabajadoresenlosSitiosdeVacunacionContraelVirusCOVID-19#~#756925#~#www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
            "date-crawl": "2021-12-10 at 14:44:43",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
            "url-orig": "https://www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
            "source": "www.osha.gov",
            "date": "10/12/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "es"
        }
    },
    {
        "identifier": "spanish4330",
        "title": "Los programas sociales que transfieren dinero en efectivo pueden disminuir la mortalidad materna",
        "text": "\nlos efectos en la salud de los programas de transferencia monetaria en los países de ingresos bajos y medianos es particularmente relevante en la crisis económica mundial actual causada por la COVID-19, que probablemente durará, porque estas intervenciones que mitigan la pobreza podrían ayudar a las poblaciones más empobrecidas, concluye Rasella.\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
            "id": "Losprogramassocialesquetransfierendineroenefectivopuedendisminuirlamortalidadmaterna-News-ISGLOBAL#~#8700#~#www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
            "date-crawl": "2021-06-22 at 06:46:12",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
            "url-orig": "https://www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
            "source": "www.isglobal.org",
            "date": "22/06/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "es"
        }
    },
    {
        "identifier": "swedish1333",
        "title": "Health declaration adult vaccination against COVID-19",
        "text": "\npå immunförsvar på grund av sjukdom eller behandling. Om personen svarat JA på fråga 5: om personen är nyligen vaccinerad ska minst 7 dagar ha passerat sedan dess för att vaccination mot covid-19 ska kunna vara aktuell. Nedan ifylls av vaccinationsmottagningen: Covid-19-vaccin namn: Dos 1 ❏ Dos 2 ❏ Dos 3 ❏ Batch-/lotnummer: Vaccinet har getts i: Höger arm ❏ Vänster arm ❏ Ev. annan\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
            "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#119078#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
            "date-crawl": "2021-10-13 at 21:51:29",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
            "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
            "source": "www.folkhalsomyndigheten.se",
            "date": "13/10/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "sv"
        }
    },
    {
        "identifier": "swedish3091",
        "title": "Health declaration adult vaccination against COVID-19",
        "text": "\nKronisk lever- eller njursvikt.\n' Tillstånd som innebär påverkan på immunförsvar på grund av sjukdom eller behandling.\nOm personen svarat JA på fråga 5: om personen är nyligen vaccinerad ska minst 7 dagar ha passerat sedan dess för att vaccination mot covid-19 ska kunna vara aktuell.\nNedan ifylls av vaccinationsmottagningen: Covid-19-vaccin namn: Dos 1 ' \"  Dos 2 ' \"  Batch-/lotnummer: Vaccinet har getts i: Höger arm ' \"  Vänster arm ' \"  Ev. annan lokalisation för administrering: Ev. kommentar: Vårdgivare: Mottagning/enhet: Vaccinatörens namn: Signatur: FOLKHÄLSOMYNDIGHETEN,\n2021\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
            "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#137945#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
            "date-crawl": "2021-07-01 at 19:01:11",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
            "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
            "source": "www.folkhalsomyndigheten.se",
            "date": "01/07/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "sv"
        }
    },
    {
        "identifier": "english2",
        "title": "COVID-19: latest updates | European Medicines Agency",
        "text": "\nEMA published new safety updates for Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna and Vaxzevria\nEMA updated the guidance on preparing risk management plans for COVID-19 vaccines\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
            "id": "COVID-19:latestupdatesEuropeanMedicinesAgency#~#310304#~#www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
            "date-crawl": "2021-06-28 at 11:36:01",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
            "url-orig": "https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
            "source": "www.ema.europa.eu",
            "date": "28/06/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "en"
        }
    },
    {
        "identifier": "english5",
        "title": "Coronavirus (COVID-19): daily data for Scotland - gov.scot",
        "text": "\n142 new cases of COVID-19 reported\n9,816 new tests for COVID-19 that reported results\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
            "id": "CoronavirusCOVID-19:dailydataforScotland-gov.scot#~#48749#~#www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
            "date-crawl": "2021-04-26 at 20:22:35",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
            "url-orig": "https://www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
            "source": "www.gov.scot",
            "date": "26/04/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "en"
        }
    },
    {
        "identifier": "dutch569",
        "title": "Staat van infectieziekten in Nederland, 2020",
        "text": "\nHet jaar 2020 gaat de geschiedenis in als het eerste jaar van de uitbraak van het SARS-CoV-2 virus (coronavirus). De Nederlandse regering trof maatregelen om de verspreiding van het coronavirus tegen te gaan. Het lijkt erop dat andere infectieziekten hierdoor ook minder voorkwamen. Er was bijvoorbeeld\ngegaan door infectieziekten. Dit wordt uitgedrukt in disability-adjusted life years (DALY’s); ook wel de ziektelast genoemd. In 2020 gingen in Nederland de meeste gezonde levensjaren verloren aan COVID-19 (169.400 DALY’s), legionella (6.300 DALY’s) en ernstige pneumokokkenziekte (6.200 DALY’s. Deze top-3 is vanwege COVID-19 anders dan eerdere jaren. In 2019 waren dat: ernstige pneumokokkenziekte\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
            "id": "StaatvaninfectieziekteninNederland,2020#~#7764#~#www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
            "date-crawl": "2021-12-13 at 19:10:10",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
            "url-orig": "https://www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
            "source": "www.rivm.nl",
            "date": "13/12/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "nl"
        }
    },
    {
        "identifier": "dutch1133",
        "title": "Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2020",
        "text": "\nwordt gevaccineerd. Dit geldt vooral voor kinkhoest, bof, meningokokkenziekte, pneumokokkenziekte en mazelen. De kans is groot dat dit vooral komt door de maatregelen die vanwege de uitbraak van het coronavirus SARS-CoV-2 zijn ingevoerd. Voorbeelden zijn handen wassen, afstand houden, de (tijdelijke) sluiting van scholen en kinderopvang, het kleinere aantal mensen bij bijeenkomsten, en het maximale aantal te ontvangen\nDe uitbraak van het coronavirus had ook gevolgen voor de manier waarop het RVP in 2020 is uitgevoerd. Groepsvaccinaties (voor de kinderen van 9 jaar en ouder) zijn eerst uitgesteld of omgezet naar individuele afspraken. Vanaf 1 juli\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
            "id": "VaccinatiegraadenjaarverslagRijksvaccinatieprogrammaNederland2020RIVM#~#8516#~#www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
            "date-crawl": "2021-07-05 at 15:57:20",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
            "url-orig": "https://www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
            "source": "www.rivm.nl",
            "date": "05/07/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "nl"
        }
    },
    {
        "identifier": "danish6948",
        "title": "Højdepunkter | Safety and health at work EU-OSHA",
        "text": "\nCovid-19: ressourcer til arbejdspladsen\n giver et overblik over, hvad der fortsat vil være relevant i fremtiden. EU-OSHA's fungerende direktør, William Cockburn, giver et overblik over nye risici, og andre kollegaer belyser den fortsatte pandemi og giver råd om tilbagevenden til\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
            "id": "HojdepunkterSafetyandhealthatworkEU-OSHA#~#124011#~#osha.europa.eu/da/highlights",
            "date-crawl": "2021-12-14 at 07:14:23",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
            "url-orig": "https://osha.europa.eu/da/highlights",
            "source": "osha.europa.eu",
            "date": "14/12/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "da"
        }
    },
    {
        "identifier": "czech5265",
        "title": "Hlavní zprávy | Safety and health at work EU-OSHA",
        "text": "\nPo skončení pandemie COVID-19 to vypadá, že práce z domova bude využívána i nadále. Co se ale můžeme naučit od společností, které práci z domova uplatňovaly již před pandemií, ohledně toho, jak zajistit\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
            "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#122694#~#osha.europa.eu/cs/highlights",
            "date-crawl": "2021-11-16 at 06:43:15",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
            "url-orig": "https://osha.europa.eu/cs/highlights",
            "source": "osha.europa.eu",
            "date": "16/11/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "cs"
        }
    },
    {
        "identifier": "czech5395",
        "title": "Hlavní zprávy | Safety and health at work EU-OSHA",
        "text": "\nCOVID-19, práce na dálku a bezpečnost a ochrana zdraví při práci: jaká ponaučení jsme získali?\nS ohledem na obrovský nárůst práce z domova způsobený pandemií COVID-19, kdy navíc mnoho zaměstnanců v práci z domova i nadále pokračuje, se nová zpráva věnuje souvisejícím bezpečnostním a zdravotním rizikům. Obsahuje hloubkové rozhovory s pracovníky\n    ",
        "metadata":
        {
            "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
            "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#123448#~#osha.europa.eu/cs/highlights",
            "date-crawl": "2021-11-28 at 06:59:15",
            "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
            "url-orig": "https://osha.europa.eu/cs/highlights",
            "source": "osha.europa.eu",
            "date": "28/11/2021",
            "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
            "language": "cs"
        }
    }
]